| 1 |
2023 |
Georgiana-Diana Cazac, Cristina-Mihaela Lăcătușu, Gabriela Ștefănescu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu, Bogdan-Mircea Mihai. Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives, Metabolites. 2023; 13: 581.
https://doi.org/10.3390/metabo13050581 |
| 2 |
2020 |
Erika Pedone, Andrea Laurenzi, Agnese Allora, Andrea Mario Bolla, Amelia Caretto. Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now?, Exploration of Medicine. 2020; 1: 314.
https://doi.org/10.37349/emed.2020.00021 |
| 3 |
2022 |
Agostino Milluzzo, Lucia Manuella, Laura Sciacca. Semaglutide: a game changer for metabolic diseases?, Exploration of Medicine. 2022; 173.
https://doi.org/10.37349/emed.2022.00083 |
| 4 |
2024 |
Rui Xiao, Yang Cao, Linlin Wang, Peijun Tian, Qixiao Zhai, Jianxin Zhao, Gang Wang, Yu Zhu. The role of probiotics in the treatment of non-alcoholic fatty liver disease (NAFLD): New insights based on meta-analysis and subgroup analysis, Food Bioscience. 2024; 62: 105454105454.
https://doi.org/10.1016/j.fbio.2024.105454 |
